Elisabeth Eiling, Michael Brandt, Thomas Schwarz, Axel Hauschild. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCetuximabColectomyColonic Neoplasms/drug therapyColonic Neoplasms/surgeryDermatologic Agents/therapeutic useFemaleHumansSkin Diseases/chemically inducedSkin Diseases/drug therapySkin Diseases/pathologyTacrolimus/analogs & derivativesTacrolimus/therapeutic use
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsDermatologic AgentspimecrolimusCetuximabTacrolimus
Year: 2008 PMID： 18794482 DOI： 10.1001/archderm.144.9.1236
Source DB: PubMed Journal: Arch Dermatol ISSN： 0003-987X